Licofelone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
- The Journal of neuroscience : the official…
- 2013
Inflammation is a major factor shaping outcome during the early, acute phase of traumatic spinal cord injury (SCI). It is known… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
- Annals of the rheumatic diseases
- 2009
OBJECTIVE
In a multicentre study to explore the effects of licofelone as a disease-modifying osteoarthritis drug in comparison… (More)
Is this relevant?
2008
2008
- The Journal of pharmacology and experimental…
- 2008
The anti-inflammatory drug licofelone [=ML3000; 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl… (More)
Is this relevant?
2007
2007
- British journal of pharmacology
- 2007
BACKGROUND AND PURPOSE
Licofelone is a dual inhibitor of the cyclooxygenase and 5-lipoxygenase (5-LO) pathway, and has been… (More)
Is this relevant?
2007
2007
- The Journal of pharmacology and experimental…
- 2007
Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better… (More)
Is this relevant?
2007
2007
- The Veterinary record
- 2007
To evaluate the effect of licofelone, an arachidonic acid substrate with combined inhibitory activity against 5-lipoxygenase and… (More)
Is this relevant?
Review
2004
Review
2004
- Rheumatology
- 2004
Licofelone, a competitive inhibitor of 5-lipoxygenase, cyclooxygenase (COX)-1 and COX-2, is currently in clinical development for… (More)
Is this relevant?
2004
2004
- American Journal of Gastroenterology
- 2004
OBJECTIVES:Concerns exist over the safety of conventional nonsteroidal antiinflammatory drugs (NSAIDs) and selective… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
- Bone
- 2004
OBJECTIVE
To evaluate the morphological changes that take place in the subchondral bone and calcified cartilage zone in the… (More)
Is this relevant?
Review
2003
Review
2003
- IDrugs : the investigational drugs journal
- 2003
EuroAlliance (a consortium of Alfa Wassermann SpA, Lacer SA and Merckle GmbH) is developing licofelone, a dual cyclooxygenase and… (More)
Is this relevant?